Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2015, Article ID 820403, 7 pages
http://dx.doi.org/10.1155/2015/820403
Research Article

The Prevalence of Cardiac Risk Factors in Men with Localized Prostate Cancer Undergoing Androgen Deprivation Therapy in British Columbia, Canada

1Division of Cardiology, University of British Columbia, Vancouver, BC, Canada V5Z 1M9
2Division of Cardiology, Royal Jubilee Hospital, Victoria, BC, Canada V8R 1J8
3Department of Radiation Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada V5Z 4E6

Received 5 September 2014; Revised 8 December 2014; Accepted 9 December 2014

Academic Editor: Daniel Lenihan

Copyright © 2015 Margot K. Davis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [16 citations]

The following is the list of published articles that have cited the current article.

  • Mohammadali Mohammadzadeh Rezaei, Alireza Ghoreifi, Behzad Feyzzadeh Kerigh, and Mohammadhadi Mohammadzadeh Rezaei, “Metabolic syndrome in patients with prostate cancer undergoing intermittent androgen-deprivation therapy,” Journal of the Canadian Urological Association, vol. 10, no. 9-10, pp. E300–E306, 2016. View at Publisher · View at Google Scholar
  • Christopher B. Johnson, Margot K. Davis, Angeline Law, and Jeffrey Sulpher, “Shared Risk Factors for Cardiovascular Disease and Cancer: Implications For Preventive Health and Clinical Care of Oncology Patients,” Canadian Journal of Cardiology, 2016. View at Publisher · View at Google Scholar
  • Richard M. Steingart, Anthony Yu, Michael Baum, Wendy Schaffer, John Sasso, Carol Chen, Jennifer Liu, Nancy Roistacher, Jonathan W. Weinsaft, Eileen McAleer, Dipti Gupta, Howard Weinstein, Lee W. Jones, Michelle Johnson, and Shawn C. Punpp. 345–378, 2016. View at Publisher · View at Google Scholar
  • Wendy Schaffer, Dipti Gupta, Anthony Yu, Jennifer Liu, Michael Baum, Howard Weinstein, Michelle Johnson, Carol Chen, Nancy Roistacher, Shawn C. Pun, Jonathan W. Weinsaft, Eileen McAleer, John Sasso, Lee W. Jones, and Richard M. Steingart, “Intratherapy Cardiology Evaluation,” Clinical Cardio-Oncology, pp. 379–395, 2016. View at Publisher · View at Google Scholar
  • Karen Poole, Lauren Turner, Sara Faithfull, and Bruce A. Griffin, “Current and future strategies for the nutritional management of cardiometabolic complications of androgen deprivation therapy for prostate cancer,” Nutrition Research Reviews, pp. 1–13, 2017. View at Publisher · View at Google Scholar
  • Pawel J. Wiechno, Grazyna M. Poniatowska, Wojciech Michalski, Jakub Kucharz, Malgorzata Sadowska, Joanna Jonska-Gmyrek, Karol Nietupski, Joanna Rzymowska, and Tomasz Demkow, “Clinical significance of androgen secretion disorders in men with a malignancy,” Medical Oncology, vol. 34, no. 7, 2017. View at Publisher · View at Google Scholar
  • Mg Rajanandh, S Suresh, K Manobala, R Nandhakumar, G Jaswanthi, and S Neha, “Prediction of cardiovascular risk in cancer patients of South India using WHO/ISH risk prediction charts and Framingham score – A prospective study,” Journal of Oncology Pharmacy Practice, pp. 107815521770733, 2017. View at Publisher · View at Google Scholar
  • Vasileios Tzortzis, Michael Samarinas, Ioannis Zachos, Athanasios Oeconomou, Louis L. Pisters, and Alexandra Bargiota, “Adverse effects of androgen deprivation therapy in patients with prostate cancer: Focus on metabolic complications,” Hormones, vol. 16, no. 2, pp. 115–123, 2017. View at Publisher · View at Google Scholar
  • Anne Blaes, Anna Prizment, Ryan J. Koene, and Suma Konety, “Cardio-oncology Related to Heart Failure,” Heart Failure Clinics, vol. 13, no. 2, pp. 367–380, 2017. View at Publisher · View at Google Scholar
  • Grazyna Poniatowska, Konrad Tałasiewicz, Tomasz Demkow, Beata Jagielska, and Paweł Wiechno, “Systemic complications in the hormonal treatment of prostate and breast cancer,” Nowotwory, vol. 67, no. 3, pp. 206–214, 2017. View at Publisher · View at Google Scholar
  • Dana Schneeberger, Mladen Golubíc, Halle C.F. Moore, Kenneth Weiss, Jame Abraham, Alberto Montero, Jonathan Doyle, Marianne Sumego, and Michael Roizen, “Lifestyle Medicine-Focused Shared Medical Appointments to Improve Risk Factors for Chronic Diseases and Quality of Life in Breast Cancer Survivors,” The Journal of Alternative and Complementary Medicine, 2018. View at Publisher · View at Google Scholar
  • Axel Merseburger, Anne Bro Falkenberg, and Olga J. Kornilova, “New study suggests patients with advanced prostate cancer on androgen deprivation therapy need more dialogue with health care provider, especially around cardiovascular risk,” World Journal of Urology, 2018. View at Publisher · View at Google Scholar
  • Mladen Golubić, Dana Schneeberger, Kristin Kirkpatrick, Judi Bar, Adam Bernstein, Fredina Weems, Jane Ehrman, Jim Perko, Jonathan Doyle, and Michael Roizen, “Comprehensive Lifestyle Modification Intervention to Improve Chronic Disease Risk Factors and Quality of Life in Cancer Survivors,” The Journal of Alternative and Complementary Medicine, 2018. View at Publisher · View at Google Scholar
  • Anne H. Blaes, Amir Lerman, Daniel A. Duprez, van Londen, and Nicole Sandhu, “Cardiovascular Risk in Breast Cancer Patients Receiving Estrogen or Progesterone Antagonists,” Current Treatment Options in Cardiovascular Medicine, vol. 20, no. 6, 2018. View at Publisher · View at Google Scholar
  • Simon G. Findlay, Jason H. Gill, Ruth Plummer, Carol DeSantis, and Chris Plummer, “Chronic cardiovascular toxicity in the older oncology patient population,” Journal of Geriatric Oncology, 2019. View at Publisher · View at Google Scholar
  • Stephen J. Freedland, Lauren Howard, Jenifer Allen, Jordan Smith, Jennifer Stout, William Aronson, Brant A. Inman, Andrew J. Armstrong, Daniel George, Eric Westman, and Pao-Hwa Lin, “A lifestyle intervention of weight loss via a low-carbohydrate diet plus walking to reduce metabolic disturbances caused by androgen deprivation therapy among prostate cancer patients: carbohydrate and prostate study 1 (CAPS1) randomized controlled trial,” Prostate Cancer and Prostatic Diseases, 2019. View at Publisher · View at Google Scholar